Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin

Pathology Research and Practice

Volumn 196, Issue 1, 2000, Pages 1-7

  Motoi, Noriko ^a,b   Sakamoto, Atsuhiko ^c   Yamochi, Tadanori ^d   Horiuchi, Hajime ^e   Motoi, Toru ^a   Machinami, Rikuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c KYORIN UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TORANOMON HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Point mutation; Ras oncogene; Thyroid cancer; Tumor progression

Indexed keywords

PROTEIN P21;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; ONCOGENE RAS; POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TUMOR GROWTH;

EID: 0033984548     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80015-1     Document Type: Article

References (19)

1. Bond J, Dawson T, Lemoine N, Wynford-Thomas D (1992) Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras. Molecular Carcinogenesis 5: 129-135
2. Bos JL (1989) Ras oncogenes in human cancer: A review: Cancer Res 49: 4682-4689
3. Burns JS, Blaydes JP, Wright PA (1992) Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: An in vitro model of tumor progression. Molecular Carcinogenesis 6: 129-139
4. Farid NR, Shi Y, Zou M (1994) Molecular basis of thyroid cancer. Endocr Rev 15: 202-232
5. Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. Second edition. In: World Health Organization. International histological classification of tumours series, volume 11. Berlin, Springer-Verlag
6. Horie H, Yokogishi Y, Tsuyuguchi M, Saito S (1995) Point mutation of ras and Gsa subunit genes in thyroid tumors. Jpn J Cancer Res 86: 737-742
7. Janssen JWG, Lyons J, Steenvoorden ACM, Seliger H, Bartram CR (1987) Concurrent mutations in two different ras genes in acute myelocytic leukemias. Nucleic Acids Res 15. 5669-5680
8. Johnson TL, Lyoyd RV, Thor A (1987) Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues. Am J Pathol 127: 60-65
9. Karga H, Lee JK, Vickery AL Jr, Thor A, Gaz RD, Jameson JL (1991) ras Oncogene mutation in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 73: 832-836
10. Lemoine NR, Mayall ES, Williams ED, Thurston and Wynford-Thomas D (1988) Agent specific ras oncogene activation. Oncogene 3. 541-544
11. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, et al (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4: 159-164
12. Lowy DR, Willumsen BM (1993) Function and regulation of ras. Annu Rev Biochem 62: 851-891
13. Mizukami Y, Nonomura A, Hashimoto T, Kawahara E, Matsukawa S, Matsubara F (1988) Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Cancer 61. 873-880
14. Namba H, Rubin SA, Fagin JA (1990) Point mutation of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 4: 1474-1479
15. Oyama T, Suzuki T, Hara F, Iino Y, Ishida T, Sakamoto A, et al (1995) N-ras mutation of thyroid tumor with special reference to the follicular type. Pathol International 45: 45-50
16. Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52. 1849-1855
17. Shi YF, Zou MJ, Schmidt H, Juhasz F, Stensky V, Robb D, et al (1991) High rate of ras codon 61 mutation in thyroid tumors in an iodine-deficient area. Cancer Res 51: 2690-2693
18. Suarez HG, Du VJ, Caillous B, Schlumberger M, Tubiana M, Permentier C, et al (1988) Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene 2: 403-406
19. Yoshida K, Hamatani K, Koide H, Ikeda H, Nakamura N, Akiyama M, et al (1988) Preparation of anti-ras Mr21000 protein monoclonal antibodies and immunohistochemical analysis on expression of ras genes in human stomach and thyroid cancers. Cancer Res 48: 5503-5509